• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

蜕膜对尿激酶诱导的纤维蛋白溶解及大鼠卵子纤维蛋白溶解活性的抑制作用。

Inhibitory effect of decidua on fibrinolysis induced by urokinase and by the fibrinolytic activity of the rat ovum.

作者信息

Liedholm P, Astedt B

出版信息

Acta Obstet Gynecol Scand. 1976;55(3):217-9. doi: 10.3109/00016347609156916.

DOI:10.3109/00016347609156916
PMID:936985
Abstract

With the use of a technique, which permits the study of fibrinolytic enzymes and inhibitors in organ culture, human decidua was found to produce inhibitors capable of inhibiting plasminogen activation induced by urokinase as well as activators released from kidney explants. Also the medium in which rat and human decidua had been cultured was found to inhibit fibrinolytic activity of the rat ovum. The inhibitors emanating from the decidua are presumably of importance for facilatating the implantation of ova.

摘要

利用一种可在器官培养中研究纤溶酶和抑制剂的技术,发现人蜕膜能产生抑制剂,这些抑制剂既能抑制由尿激酶诱导的纤溶酶原激活,也能抑制从肾外植体释放的激活剂。此外,还发现培养过大鼠和人蜕膜的培养基能抑制大鼠卵子的纤溶活性。来自蜕膜的抑制剂可能对促进卵子着床具有重要意义。

相似文献

1
Inhibitory effect of decidua on fibrinolysis induced by urokinase and by the fibrinolytic activity of the rat ovum.蜕膜对尿激酶诱导的纤维蛋白溶解及大鼠卵子纤维蛋白溶解活性的抑制作用。
Acta Obstet Gynecol Scand. 1976;55(3):217-9. doi: 10.3109/00016347609156916.
2
Comparison of the relative fibrinogenolytic, fibrinolytic and thrombolytic properties of tissue plasminogen activator and urokinase in vitro.组织型纤溶酶原激活剂与尿激酶在体外的相对纤维蛋白溶解、纤溶及溶栓特性比较
Thromb Haemost. 1981 Jun 30;45(3):225-9.
3
Human urokinase and porcine tissue plasminogen activator. A comparative study of the mechanism of fibrinolysis, and the effect of natural proteinase inhibitors and omega-aminocarboxylic acids.
Dan Med Bull. 1977 Oct;24(5):189-206.
4
Substrate composition and the effect of epsilon-aminocaproic acid on tissue plasminogen activator and urokinase-induced fibrinolysis.底物组成及ε-氨基己酸对组织型纤溶酶原激活物和尿激酶诱导的纤维蛋白溶解的影响。
Thromb Diath Haemorrh. 1974 Dec 31;32(2-3):306-24.
5
Proceedings: Fibrinolysis versus fibrinogenolysis: the specificity of human vascular activator (VA) as compared to urokinase (UK) and streptokinase (SK).
Thromb Diath Haemorrh. 1975 Sep 30;34(1):351.
6
Differences in the reactivities of human urokinase and the porcine tissue plasminogen activator.
Haemostasis. 1976;5(5):295-305. doi: 10.1159/000214148.
7
[Changes in the components of the animal fibrinolytic system induced by the action of physiological activators and enzymes of fungal origin].[生理激活剂和真菌源酶作用诱导动物纤维蛋白溶解系统成分的变化]
Nauchnye Doki Vyss Shkoly Biol Nauki. 1983(3):51-4.
8
Plasma tissue-type plasminogen activator increases fibrinolytic activity of exogenous urokinase-type plasminogen activator.血浆组织型纤溶酶原激活物可增强外源性尿激酶型纤溶酶原激活物的纤溶活性。
Blood Coagul Fibrinolysis. 2012 Dec;23(8):729-33. doi: 10.1097/MBC.0b013e32835897d5.
9
Effects of pro-urokinase and urokinase on the fibrinolytic system in man.
Haemostasis. 1987;17(4):238-44. doi: 10.1159/000215750.
10
[New method of studying the release of fibrinolysis activators in tissue cultures].[研究组织培养中纤维蛋白溶解激活剂释放的新方法]
Biull Eksp Biol Med. 1977 Aug;84(8):250-3.